Showing results (501-510 of 803) with videos related to

Sort By:
Pageof 81
AJNR. American Journal of Neuroradiology|October 27, 2022
Malignant Melanotic Nerve Sheath TumorJ C Benson, M D Marais, P M Flanigan, et al.
The Neuroradiology Journal|February 5, 2020
Polyclonal lymphocytic infiltrate with arachnoiditis resulting from intrathecal stem cell transplantationAjay A Madhavan, Dan Summerfield, Christopher H Hunt, et al.
Nutrients|October 23, 2021
Leptin as a Biomarker of Stress: A Systematic Review and Meta-AnalysisJean-Baptiste Bouillon-Minois, Marion Trousselard, David Thivel, et al.
AJNR. American Journal of Neuroradiology|February 25, 2022
Reassessing the Carotid Artery Plaque "Rim Sign" on CTA: A New Analysis with Histopathologic ConfirmationJ C Benson, V Nardi, A A Madhavan, et al.
Clinical Radiology|May 24, 2023
The clue is in the kidneys: greater renal contrast medium accumulation on ipsilateral side down CT myelogram after lateral decubitus digital subtraction myelogram as a predictor of laterality of cerebrospinal fluid leakS Wagle, J C Benson, A A Madhavan, et al.
The Journal of Urology|March 21, 1998
Urinary continence after radical prostatectomy: the Columbia experienceE T Goluboff, J A Saidi, S Mazer, et al.
Urologic Oncology|December 13, 2003
Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicityJohn S Lam, Mitchell C Benson, Michael A O'Donnell, et al.
Seminars in Urologic Oncology|January 13, 2000
Prostate-specific antigen and other serum markers: current concepts from the World Health Organization Second International Consultation on Prostate CancerM K Brawer, M C Benson, D G Bostwick, et al.
BJU International|February 15, 2000
Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrenceA De La Taille, M C Benson, E Bagiella, et al.
The Journal of Urology|February 7, 2001
The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancerR D Ennis, D P Petrylak, P Singh, et al.
Pageof 81